Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · IEX Real-Time Price · USD
2.650
-0.040 (-1.49%)
At close: May 1, 2024, 4:00 PM
2.660
+0.010 (0.38%)
Pre-market: May 2, 2024, 5:02 AM EDT

Intelligent Bio Solutions Balance Sheet

Millions USD. Fiscal year is Jul - Jun.
Year 20232022202120202019
Cash & Equivalents
1.548.2412.570.430.2
Cash & Cash Equivalents
1.548.2412.570.430.2
Cash Growth
-81.34%-34.48%2842.78%115.86%-
Receivables
0.291.093.1500
Inventory
0.980000
Other Current Assets
1.051.542.491.912.13
Total Current Assets
3.8610.8718.212.342.33
Property, Plant & Equipment
1.240.39000
Long-Term Investments
0000.140
Goodwill and Intangibles
5.260000
Other Long-Term Assets
01.093.6500
Total Long-Term Assets
6.491.483.650.140
Total Assets
10.3512.3521.862.482.33
Accounts Payable
2.611.631.482.561.17
Deferred Revenue
2.343.935.2500
Current Debt
0.58005.135.13
Other Current Liabilities
0.36-0.89-3.0500
Total Current Liabilities
5.884.663.687.696.31
Long-Term Debt
0.760000
Other Long-Term Liabilities
0.021.143.1700
Total Long-Term Liabilities
0.781.143.1700
Total Liabilities
6.675.816.857.696.31
Total Debt
1.34005.135.13
Debt Growth
---0.05%-
Retained Earnings
-41.81-31.18-22.87-15.83-12.67
Comprehensive Income
-0.58-0.79-0.66-0.36-0.22
Shareholders' Equity
3.86.6215.06-5.19-3.98
Net Cash / Debt
0.28.2412.57-4.71-4.93
Net Cash / Debt Growth
-97.55%-34.48%---
Net Cash Per Share
2.41134.82289.75-132.73-141.25
Working Capital
-2.026.214.52-5.35-3.98
Book Value Per Share
45.38108.42346.99-146.26-113.89
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).